Mostrar el registro sencillo del ítem
dc.contributor.author
Fraunhoffer Navarro, Nicolas Alejandro
dc.contributor.author
Abuelafia, Analía Meilerman
dc.contributor.author
Dusetti, Nelson
dc.contributor.author
Iovanna, Juan Lucio
dc.date.available
2023-09-26T16:15:19Z
dc.date.issued
2022-10
dc.identifier.citation
Fraunhoffer Navarro, Nicolas Alejandro; Abuelafia, Analía Meilerman; Dusetti, Nelson; Iovanna, Juan Lucio; Limitation and challenges in using pancreatic cancer-derived organoids as a preclinical tool; John Wiley & Sons; Cancer Communications; 42; 10; 10-2022; 1028-1031
dc.identifier.uri
http://hdl.handle.net/11336/213097
dc.description.abstract
Pancreatic ductal adenocarcinoma (PDAC) is a dismaldisease with a fast evolution and unpredictable treatmentresponse. Nowadays, FOLFIRINOX and gemcitabine are the preferred treatments with a response rateof 33% and 11%, respectively. This poor patient responsehas been associated with an inefficient/non-personalizedtreatment allocation. Consequently, developing a rapidand efficient preclinical tool to test tumor drug sensitivityfor each patient is hugely needed. Biopsy patient-derivedorganoid (PDO) appears to be a promising tool for devel-oping individualized treatments for patients with PDAC.Several PDO-based platforms are in development world-wide as a guide to optimize therapy by directing tailored treatments.
dc.format
application/pdf
dc.language.iso
eng
dc.publisher
John Wiley & Sons
dc.rights
info:eu-repo/semantics/openAccess
dc.rights.uri
https://creativecommons.org/licenses/by-nc-nd/2.5/ar/
dc.subject
PDAC
dc.subject
ORGANOIDS
dc.subject
PRECLINICAL MODELS
dc.subject.classification
Patología
dc.subject.classification
Medicina Básica
dc.subject.classification
CIENCIAS MÉDICAS Y DE LA SALUD
dc.title
Limitation and challenges in using pancreatic cancer-derived organoids as a preclinical tool
dc.type
info:eu-repo/semantics/article
dc.type
info:ar-repo/semantics/artículo
dc.type
info:eu-repo/semantics/publishedVersion
dc.date.updated
2023-07-06T22:34:06Z
dc.identifier.eissn
2523-3548
dc.journal.volume
42
dc.journal.number
10
dc.journal.pagination
1028-1031
dc.journal.pais
Reino Unido
dc.journal.ciudad
Londres
dc.description.fil
Fil: Fraunhoffer Navarro, Nicolas Alejandro. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Centro de Estudios Farmacológicos y Botánicos. Universidad de Buenos Aires. Facultad de Medicina. Centro de Estudios Farmacológicos y Botánicos; Argentina. Aix-Marseille University; Francia
dc.description.fil
Fil: Abuelafia, Analía Meilerman. Aix-Marseille University; Francia
dc.description.fil
Fil: Dusetti, Nelson. Aix-Marseille University; Francia
dc.description.fil
Fil: Iovanna, Juan Lucio. Aix-Marseille University; Francia
dc.journal.title
Cancer Communications
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/url/https://onlinelibrary.wiley.com/doi/10.1002/cac2.12335
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/doi/http://dx.doi.org/10.1002/cac2.12335
Archivos asociados